- Home
- IRON vs DNN Comparison
IRON vs DNN Comparison
Compare IRON & DNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- DNN
- Stock Information
- Founded
- IRON 2017
- DNN 1936
- Country
- IRON United States
- DNN Canada
- Employees
- IRON N/A
- DNN N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- DNN Other Metals and Minerals
- Sector
- IRON Health Care
- DNN Basic Materials
- Exchange
- IRON Nasdaq
- DNN Nasdaq
- Market Cap
- IRON 1.4B
- DNN 1.2B
- IPO Year
- IRON N/A
- DNN 1997
- Fundamental
- Price
- IRON $44.24
- DNN $1.55
- Analyst Decision
- IRON Strong Buy
- DNN Strong Buy
- Analyst Count
- IRON 10
- DNN 2
- Target Price
- IRON $83.80
- DNN $3.00
- AVG Volume (30 Days)
- IRON 397.9K
- DNN 59.2M
- Earning Date
- IRON 05-07-2025
- DNN 05-20-2025
- Dividend Yield
- IRON N/A
- DNN N/A
- EPS Growth
- IRON N/A
- DNN N/A
- EPS
- IRON N/A
- DNN N/A
- Revenue
- IRON N/A
- DNN $2,796,002.00
- Revenue This Year
- IRON N/A
- DNN $288.69
- Revenue Next Year
- IRON N/A
- DNN $22.40
- P/E Ratio
- IRON N/A
- DNN N/A
- Revenue Growth
- IRON N/A
- DNN 116.87
- 52 Week Low
- IRON $28.25
- DNN $1.08
- 52 Week High
- IRON $68.73
- DNN $2.47
- Technical
- Relative Strength Index (RSI)
- IRON 45.99
- DNN 62.44
- Support Level
- IRON $40.36
- DNN $1.39
- Resistance Level
- IRON $47.21
- DNN $1.57
- Average True Range (ATR)
- IRON 2.87
- DNN 0.07
- MACD
- IRON 0.10
- DNN 0.02
- Stochastic Oscillator
- IRON 37.67
- DNN 93.55
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. The company has an effective 95% interest in its flagship Wheeler River Uranium Project, which is the largest undeveloped uranium project in the infrastructure-rich eastern portion of the Athabasca Basin region of northern Saskatchewan. The company is also engaged in mine decommissioning and environmental services through its Closed Mines group, which manages its Elliot Lake reclamation projects and provides third-party post-closure mine care and maintenance services.